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Abstract
Background: Feedback tools for clinical audit data that compare site-specific results to average performance over
all sites can be useful for quality improvement. Proposed tools should be simple and clearly benchmark the site’s
performance, so that a relevant action plan can be directly implemented to improve patient care services. We
aimed to develop such a tool in order to feedback data to UK HIV clinics participating in the 2015 British HIV
Association (BHIVA) audit assessing compliance with the 2011 guidelines for routine investigation and monitoring
of adult HIV-1- infected individuals.
Methods: HIV clinic sites were asked to provide data on a random sample of 50–100 adult patients attending for
HIV care during 2014 and/or 2015 by completing a self-audit spreadsheet. Outcomes audited included the
proportion of patients with recorded resistance testing, viral load monitoring, adherence assessment, medications,
hepatitis testing, vaccination management, risk assessments, and sexual health screening. For each outcome we
benchmarked the proportion for a specific site against the average performance. We produced performance charts
for each site using boxplots for the outcomes. We also used the mean and differences from the mean performance
to produce a dashboard for each site. We used principal components analysis to group correlated outcomes and
simplify the dashboard.
Results: The 106 sites included in the study provided information on a total of 7768 patients. Outcomes capturing
monitoring of treatment of HIV-infection showed high performance across the sites, whereas testing for hepatitis,
and risk assessment for cardiovascular disease and smoking, management of flu vaccination, sexual health screening,
and cervical cytology for women were very variable across sites. The principal components analysis reduced the
original 12 outcomes to four factors that represented HIV care, hepatitis testing, other screening tests, and resistance
testing. These provided simplified measures of adherence to guidelines which were presented as a 4 bar dashboard of
performance.
Conclusion: Our dashboard performance charts provide easily digestible visual summaries of locally relevant audit data
that are benchmarked against the overall mean and can be used to improve feedback to HIV services. Feedback from
clinicians indicated that they found these charts acceptable and useful.
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Background
Over the last two decades, HIV organisations and
healthcare professionals worldwide have released
many sets of clinical guidelines to improve the quality
of care that HIV-infected patients receive. In the UK,
guidelines for HIV care and treatment are provided
by the British HIV Association (BHIVA) and are en-
dorsed by the National Institute for Health and Care
Excellence (NICE).
The potential benefits and harms of the existence of
clinical guidelines, in general, are discussed by S.H.
Woolf et al., 1999 [1]. The main concern about clinical
guidelines is their adequacy to cover all individual pa-
tients with the same efficiency. Regarding HIV guidelines
in particular, the research findings on the disease and its
treatment over the years have been systematically imple-
mented to produce evidence-based recommendations in
order to maximise benefits and minimise any risks for
patients’ health care.
Unfortunately, clinical guidelines themselves do not
ensure that a given patient receives the proper care. A
commonly used method for assessing the level at which
the guidelines are followed by local sites is to conduct
an audit survey. An audit, as with all types of evaluation,
should be planned in such way that it will give credible
information about the outcomes of interest [2, 3]. The
feedback from the audit should be used as a tool for
quality improvement [4]. Even though some studies have
shown that audit and feedback do not have a great effect
in general [5, 6], audit can provide an opportunity to im-
prove the quality of professional practice [7].
If the cohort on which the audit is applied involves
many sites (clinics), feedback is usually addressed to
all participating clinics/bodies in total by publishing a
report with the findings of the survey. However, feed-
back could be more influential if, in addition to the
aggregated report, another feedback document were
produced for each site individually, which would com-
pare the results of the specific site with the rest of
the participating sites. The main concern with imple-
menting this practice is the cost in terms of time and
money. The design of a common document template
into which audit data could be fed for each site sep-
arately could minimise these costs.
A very efficient method commonly used for the
provision of feedback to clinics when benchmarking of
performance is required, is the use of performance
charts. There are several ways of constructing such
charts, depending on the information to be represented.
Some of the advantages of performance charts compared
to written reports are that, if designed properly, they are
easy to read, convey much information, and are appro-
priate for comparison purposes [8, 9]. A disadvantage of
this method is that if there are many items of data,
charts may become too busy. Moreover, if items are
strongly correlated then there will be redundancy in the
information presented and trends in performance of dif-
ferent aspects of care may be more difficult to define as
many indicators will show similar performance. A more
useful approach could be to aggregate correlated items
to minimise the potential repetitiveness of the feedback
and avoid redundancy.
In 2015, BHIVA conducted a national audit survey in
order to assess the compliance of UK HIV health clinics
with the 2011 BHIVA guidelines for routine investiga-
tion and monitoring of adult HIV-1- infected individuals
[10]. The survey collected data on a number of out-
comes, described in detail in the methods section of this
paper, for which the sites had specific guidelines. The
audit report derived from the survey [11] gives a detailed
analysis of the aggregated performance of the participat-
ing sites, comparing the results with the target values set
for the outcomes.
The aim of this article is to propose a feedback tool
that can be sent to each of the participating HIV clinics
and adapted for other clinical situations, which can be
used for the quality improvement of the aspects of care
where the site seems to underperform compared to the
other sites. The proposed tool should give a clear indica-
tion of the benchmark of the site’s performance, so that
a relevant action plan can be directly implemented in
order to improve the care services the site provides to
the patients. Using the BHIVA audit data we developed
charts that show the performance of each site relative to
the distribution of performance in all sites, and dash-
boards which benchmark to the mean performance and
show difference of each site’s performance from the
mean. We then accounted for correlations between as-
pects of HIV care in order to produce simplified charts
for use by HIV health care providers.
Methods
Data collection
The data were collected between June–August 2015 as
BHIVA’s annual audit project for that year. UK clinic
services providing specialist HIV care were invited to
provide data on a sample of 50–100 patients by complet-
ing a self-audit spreadsheet [12]. The spreadsheet in-
cluded a list of random numbers which clinics were
asked to match against a de-duplicated list of all adult
patients (aged 16 or over) seen for HIV care during 2014
and/or 2015 (e.g. as prepared for public health surveil-
lance reporting) to generate a random sample.
The outcomes we focussed on are described in Table 1,
where the dichotomization of the outcomes is also ex-
plained by clarifying what is considered to be the positive
case for each outcome. The last column of the table states
the inclusion criteria for patients for each outcome.
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Statistical analysis
Summary statistics
The software used for the following statistical analysis
and the proposed graphical methods for performance
benchmarking, was StataMP 14 [13].
For each of the 15 outcomes, we tabulated the
number of sites contributing data, the total number
of patients audited, and the mean, standard deviation,
minimum and maximum proportion of patients with
a positive outcome across all sites. To show summary
statistics on the proportion of positive cases for each
outcome, we plotted boxplots for the outcomes over
all sites. The median is shown inside the box which
extends from the 25th to 75th percentile, the whis-
kers show the central 95% of the distribution and
outliers are shown as separate points. Note that for
some outcomes the distribution is truncated at the
upper end because sites achieved 100% positive cases.
Site-specific statistics used to create performance charts
To benchmark the proportion of positive cases for a
specific site against the average performance, for each
site separately we superimposed the site’s estimated
proportion (marked by a white triangle) with 95%
confidence interval onto the boxplot showing the overall
summary statistics. The site’s proportion for each
outcome was estimated by the proportion of patients in
the sample with the positive outcome as described in
Table 2. The 95% confidence interval was calculated for
this point estimate. We produced performance charts with
boxplots for each outcome in the audit for each site.
Table 1 Outcomes assessed in the 2015 BHIVA Audit with
inclusion criteria for patients
Outcome Explanation of
positive outcome
Inclusion criteria
for patients
Resistance done Resistance test done
and/or sample stored
All
VL measured Viral load (VL) measured
within past 6 months
Patients
on ART
Adherence
assessed
Adherence assessed
within past year
Patients
on ART
Medications
recorded
All medication recorded
within past year
Patients
on ART
Hep A immune Vaccinated or otherwise
immune to hepatitis A
All
HBsAg known Hepatitis B surface antigen
(HBsAg) status is known
All
Hep C tested Hepatitis C (Hep C) antibody
status is known
All
CVD risk assessed Cardiovascular disease (CVD)
risk assessed, within past
3 years if on ART, ever if
not on ART
All
Smoking assessed Smoking status recorded
within past two years
All
Flu vaccination
managed
Flu vaccination recorded
as done, or recorded as
advised to obtain from
General Practice
(GP) within past year
All
SH screening
offered
Sexual health (SH)
screening offered within
past year
All
Cervical cytology
managed
Cervical cytology recorded
as done, or recorded as
advised to obtain elsewhere,
within past year
Females
BMD measured Bone mineral density (BMD)
measured
Age > 70 and on
ART
FRAX risk
assessed
Fracture risk assessed within
past 3 years
Age > 50
Pneumococcus
vaccinated
Vaccinated against
pneumococcus
CD4 > 200 cells/mL
ART antiretroviral therapy
Table 2 Summary statistics on the proportion of positive
outcomes for all sites
Outcome
(BHIVA
2015 audit)
Number
of sites
Number
of patients
Mean
(of sites)
St.
dev
Min Max
Resistance
done
106 7768 81.0% 12% 42.0% 100.0%
Viral load
measured
106 6978 89.5% 10% 32.6% 100.0%
Adherence
assessed
106 6978 93.7% 9% 45.5% 100.0%
Medications
recorded
106 6978 89.4% 12% 44.7% 100.0%
Hep A immune 106 7768 60.3% 28% 0.0% 100.0%
HBsAg known 106 7768 92.5% 16% 0.0% 100.0%
Hep C tested 106 7768 96.3% 6% 52.0% 100.0%
CVD risk
assessed
106 7768 43.6% 28% 0.0% 100.0%
Smoking
assessed
106 7768 65.9% 26% 0.0% 100.0%
Flu vaccination
managed
106 7768 55.3% 33% 0.0% 100.0%
Sexual health
screening offered
106 7768 64.8% 23% 6.0% 98.1%
Cervical cytology
managed
106 2663 74.6% 18% 9.1% 100.0%
Bone mineral
density measured
70 150 17.4% 31% 0.0% 100.0%
FRAX risk
assessed
106 2413 17.9% 24% 0.0% 93.8%
Pneumococcus
vaccinated
106 7411 25.1% 31% 0.0% 100.0%
CVD cardiovascular disease; Hep hepatitis; HBsAg hepatitis B surface antigen
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Presentation of site-specific data using benchmarked
dashboards
In addition to using box plots based on the median and
the distribution of positive outcomes across all sites to
benchmark each site’s performance, we also used
dashboards based on the mean values. In particular, a
template dashboard for each outcome was produced, on
which was marked the overall mean (marked as a
vertical black bar) and coloured bands representing dif-
ference in performance from the mean (Fig. 1). We de-
fined performance for each outcome separately based on
the following percentage cut-offs relative to the mean: bet-
ter than expected (>110% green), as expected (90–110%
grey), worse than expected (80–90% orange), and much
worse than expected (<80% red) performance (Fig. 1).
Then, in a similar way to the performance charts, the indi-
vidual site estimated proportion (white triangle) and 95%
confidence interval (horizontal blue bar) were positioned
on the template to show the benchmarked performance
for the outcome.
Data reduction using principal component analysis – Simplified
performance charts
We estimated correlations between outcomes to see if
outcomes could be grouped. Some of the outcomes were
clearly related, for example, the three outcomes on hepa-
titis A, B and C, therefore we used principal components
analysis (PCA) to reduce the number of data items. The
PCA was done using the rankings of the site propor-
tions, instead of the proportions themselves, in order to
eliminate the difference in variability between the
outcomes. If a site had the highest proportion for an
outcome then it would be ranked 1st, the second highest
would be ranked 2nd and so on. Where there were
equalities, the average rank was assigned. Then, 5 groups
of rankings were formed according to quintiles of the
sites (1–21, 22–42, 43–63, 64–84 and 85–106). Hence,
for each of the outcomes, every site would lie in one of
the 5 ranking groups. The groups were formed because
for some outcomes the distribution of values was very
dense. Hence, a big difference in ranking did not neces-
sarily correspond to a big difference in the actual pro-
portion of positive cases. In the PCA, we retained
factors if their eigenvalue was >1 and used loading size
(nominally using threshold of 0.4) to allocate outcomes
to factors. The results of the rotated PCA indicated four
factors could represent the outcomes. Hence, for each of
the factors we created a score by taking the unweighted
average of the proportions of positive cases of the corre-
sponding outcomes included in the factor. We then pro-
duced performance charts for each site with the number
of boxplots or dashboards reduced to four using the
same groupings of outcomes derived from PCA.
Analyses were conducted in part through the National
Institute for Health Research Units (NIHR HPRUs) in
Evaluation of Interventions (University of Bristol) and
Blood Borne and Sexually Transmitted Infections
(University College London in collaboration with
London School of Hygiene and Tropical Medicine), both
of which are in partnership with Public Health England.
Results
Summary statistics
A completed self-audit spreadsheet was returned by 123
clinic sites, of which 17 were excluded because they pro-
vided data on fewer than 40 patients. 16 (94%) of 17 ex-
cluded sites were outside London, as compared with 89
(85%) of 106 included sites. A sensitivity analysis was
performed to test whether removal of these sites would
result in significant differences in the overall mean of
each of the outcomes. Results showed that there were
no systematic differences. Removal of the 17 clinics re-
sulted only in small differences: the largest observed for
the CVD risk assessed outcome (+1.7%) and the Smok-
ing assessed outcome (−1.1%) (see, in Additional file 1:
Table S1).
The 106 sites included in the study provided informa-
tion on a total of 7768 patients. A summary of the pro-
portion of positive cases for each outcome is given in
Table 2 and their distribution is illustrated in Fig. 2 using
Fig. 1 Explanation of dashboard coloured areas which show differences from the overall mean. Legend: The black vertical line shows the overall
proportion (mean) for all sites. The coloured areas indicate the performance of the site. Grey area corresponds to values between 90%–110% of
the overall mean (sites falling in this area are considered to perform as expected). Green area corresponds to values >110% of the overall mean
(sites falling in this area are considered to perform better than expected). Orange area corresponds to values between 80%–90% of the overall
mean (sites falling in this area are considered to perform worse than expected). Red area corresponds to values <80% of the overall mean (sites
falling in this area are considered to perform much worse than expected). The white triangle shows the estimated proportion (score) for the site
in question and the blue bar gives the 95% confidence interval for the site’s proportion. In this graph, the estimated score falls within the grey
area, so there is no strong evidence of bad performance
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a boxplot showing their variability. The first four out-
comes which capture monitoring of treatment of HIV-
infection show high performance across the sites,
whereas testing for hepatitis A and B appears not to be
done at all in some sites. Assessments of cardiovascular
disease (CVD) risk and smoking, management of flu vac-
cination, sexual health screening, and cervical cytology
for women are also very variable across sites. The last
three outcomes, measuring bone mineral density, asses-
sing fracture risk, and offering pneumococcal vaccin-
ation show very low overall performance. Despite
accounting for eligibility of patients, the audit shows that
recommended guidelines are poorly adhered to for these
three outcomes. The audit recommended implementing
an action plan for these three outcomes across all sites
and therefore we excluded them from further compari-
sons between sites, thus the following analysis includes
only the first 12 outcomes. A more detailed analysis of
the outcomes and the target values for each of them has
been published elsewhere [11].
Site-specific performance charts and dashboards
An example of a performance chart is shown in Fig. 3
which compares the performance of site 1 with the per-
formance of all sites. This uses the boxplot showing the
distribution of site performances (Fig. 2 minus the out-
liers for clarity) as a template and superimposes the
mean and 95% confidence intervals for site 1 for each
outcome. The chart shows analytically (for each out-
come) where the score of the site is ranked in
comparison with the other sites. Form the graph it is
clear that site 1 performs relatively badly for resistance
testing and sexual health screening outcomes (although
it is not an outlier), but performs better than 50% of the
sites for recording medications and is within the inter-
quartile range for all other outcomes.
The alternative representation of performance using
the dashboard to show the percentage difference be-
tween the site-specific performance and the mean per-
formance across all sites is shown for site 1 in Fig. 4.
This representation shows that 6 out of the 12 outcomes
are in the red band denoting much worse performance
than average. Two outcomes, CVD risk assessment and
sexual health screening, have their entire 95% confidence
interval in the red section, showing that poor perform-
ance cannot be attributed to sampling variation.
Data reduction using PCA – Simplified performance charts
In the PCA there were four factors with eigenvalues >1
which were retained in the model (in Additional file 1:
Table S2). These results showed that we may reduce the
number of outcomes by replacing them with four
representative factors. The loadings for the factors (in
Additional file 1: Table S3) were used to identify the
factors and allocate outcomes to them. The proposed
factors were:
Factor 1 (HIV Care): Viral load done, adherence
assessed, medications recorded.
0 .1 .2 .3 .4 .5 .6 .7 .8 .9 1
Cerv. cyt. managed
SH screen offered
Flu vax managed
Smoking assessed
CVD risk assessed
HCV tested
HBsAg known
Hep A immune
Meds recorded
Adherence assessed
VL measured
Resistance done
Fig. 2 Boxplots showing the distribution of site performances for each outcome. Legend: The main body of a boxplot (coloured box) covers the
range between the lower and upper quartiles. The white vertical line shows the position of the mean. The lines (whiskers) outside the boxes are
extended as to cover all data points that lie within ±1.5 IQR (interquartile range, which is the difference between the upper and lower quartiles)
form the upper and lower quartiles respectively. The dots indicate the points falling beyond the whiskers and they are usually considered to be
outliers (the boxplot were constructed in STATA. A more detailed analysis of boxplot can be found in [20])
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Factor 2 (Hepatitis testing): Hep A immune, HBsAg
known, Hep C tested.
Factor 3 (Other Screening tests): CVD risk assessed,
Smoking assessed, Flu vaccination managed, sexual
health screening offered, cervical cytology managed.
Factor 4: Resistance testing.
We allocated the outcome cervical cytology manage-
ment to factor 3 even though it had larger loadings for
factors 1 and 2 as clinically it is more reasonable to group
it with the screening outcomes in factor 3. The simplified
dashboard for site 1 is shown in Fig. 5 based on the four
factors derived from the 12 original outcomes. Even
though the information for each outcome separately is no
longer available from the simplified dashboard, it is now
easier to read the results and have a clearer idea on how
the clinic is performing compared to other clinics in each
of the four aspects of clinical services for HIV. In particu-
lar, the example clinic showed adequate performance in
HIV care and Hepatitis testing, whilst resistance testing
and other screening were less frequently performed than
in other clinics (Fig. 5).
Discussion
Using the 2015 BHIVA audit data, we have proposed
two different ways of visually presenting clinics with
Fig. 3 Example of Boxplots-Performance Chart - result for example site. Legend: The boxplots are the same as in Fig. 2 except that the outliers
here are removed for clarity. The estimated scores of the site, for each outcome, are represented by the white triangles. The horizontal black lines
give the 95% confidence intervals for the site’s scores
Fig. 4 Example of Dashboard showing benchmarked performance for example site. Legend: The colourings on the chart are explained
analytically in Fig. 1. For the specific site, we observe that the scores and 95% CI for outcomes SH screening offered and CVD risk assessed, fall
completely within the red areas, indicating a very poor performance. A similar situation is observed for Resistance done, Hep A immune, Smoking
assessed and Flu vax managed where the estimate proportions fall within the red area, however the CI indicate that the true proportions could
be less worrying. For all other outcomes the results are as expected
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site-specific audit outcomes benchmarked against the
corresponding overall average outcomes.
For the specific outcomes, the overall average of the
outcomes was preferred as a criterion for assessing
the performance of the clinics, instead of using target
values suggested by clinical guidelines. The reason is
that most of these target values, if they exist, are not
evidence-based and they are usually arbitrarily set by
what experts believe that clinical services ought to be
able to achieve. Thus, comparison with the actual
mean performance was considered a more valid
approach. However, in cases where the target values
of clinical guidelines are the primary aim of an audit,
the proposed methodology could still be applied with
slight modifications.
Both the boxplot and the dashboard performance
charts give an immediate impression of how a
particular clinic is performing compared with the
average over all clinics. The boxplot chart locates the
clinic position relative to the ranking of all clinic
sites, whereas the dashboard illustrates an absolute
measure of performance in bands centred on the
mean performance.
The first performance charts we constructed
showed information for all of the audit outcomes,
however, participating clinics required an easily inter-
pretable summary of the results which was best
represented by less detailed graphs. We have shown
the feasibility of using PCA to group similar out-
comes and simplify the format of the performance
charts by reducing the number of boxplots or dash-
boards. Represented in this way, with grouping of
correlated variables, it is much easier to assess where
to direct change. The proposed performance charts
can be used to inform HIV care and improve service
delivery in a locally relevant way. Acceptability and
usefulness of the dashboards were assessed via a well-
attended open forum at BHIVA conference in April
2016 where we presented different ways of visualising
outcomes data and facilitated clinicians in discussing
the merits of each. While this forum did not have the
rigour of a formal focus group, it did indicate that
clinicians preferred the simplified dashboard format
and judged it to be useful. In feeding back to clinical
services we did provide them with their data for each
individual indicator as well as the clustered factors
shown in the dashboard. Furthermore, similar
methods could be adapted for use in audits of other
clinical services.
Whilst in general the standard of HIV care in the
UK is considered to be very good [14], the audit
does highlight gaps in adherence to guideline recom-
mendations, particularly with respect to screening
and risk assessment for co-morbid conditions com-
monly found in people living with HIV. These gaps
may be more likely to be addressed when highlighted
at the local level as we have tried to do with these
site-specific performance charts. Although only some
of the clinics may be able to offer a full range of
services on their own site, all clinics can adhere to
guidelines by appropriately referring patients to other
providers of such services. For example, patients may
need to see their General Practitioner (GP) in order
to be vaccinated against influenza. It is likely in the
future that HIV services will become more con-
strained to deliver only treatment and care for a pa-
tient’s HIV infection. This will make it even more
important that patients are correctly signposted to
Fig. 5 Dashboard using the four factors showing benchmarked performance for example site. Legend: The PCA suggests the use of 4 factors instead
of the 12 outcomes. So, for the example site (same as the one used for Fig. 4) the performance for HIV care and Hep A, B, C is as expected. On the
other hand the performance for Resistance done (this is the same as in Fig. 4) and especially Other Screening is much worse than expected
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primary and secondary care services that guidelines
recommend they receive.
Context
BHIVA has conducted audits since 2001, mainly by
asking clinicians to retrospectively review individual pa-
tient case-notes, as in this instance. The aim of its audit
programme is to assess how well routinely delivered
adult HIV care adheres to existing standards and guide-
lines, so as to identify areas for quality improvement at
national and individual service-provider levels.
The audit complements research carried out by the UK
Collaborative HIV Cohort (UK CHIC). Observational
cohorts such as UK CHIC focus on patient outcomes.
These include biomarkers for assessing treatment re-
sponse and patient health, such as viral load and the CD4
count, and clinical AIDS disease and mortality, but also
monitoring of, for example, renal function, liver enzymes,
cholesterol and blood pressure. Audit outcomes focus on
processes and whether these have been carried out ac-
cording to guidelines. For example, the audit asks if the
CD4 count has been measured, whereas a research study
would analyse the values of CD4 count attained by
patients. The BHIVA audit informs on whether appropri-
ate care has been offered to patients, but not on how well
patients do. For example, a screening test can be offered
to a patient, but the patient can refuse the offer and there-
fore not benefit. The use of the term audit is not always
restricted to whether processes are followed, although it is
in our study example.
An interesting question is whether audit data
should be adjusted for patient demographics or case-
mix. Recent studies using data from UK CHIC found
that differences between clinics in the proportion of
patients with (i) low CD4 at presentation to care and
(ii) viral suppression 1 year after starting ART were
explained by patient mix [15, 16]. However, the out-
comes in the BHIVA audit appeared to be independ-
ent of patient mix and therefore did not need to be
adjusted (for further explanation of the adjustment
method used and results see Additional file 2). As
you would expect, viral load testing offered by a clin-
ician is independent of patient demographics, whereas
viral suppression, which depends on patient adherence
to ART, may depend on sex, age, ethnicity [17, 18]
and transmission risk group. Nevertheless, it is im-
portant to check independence for each outcome as,
for example, the offer of hepatitis testing could de-
pend on perceptions of the clinician about how much
‘at risk’ of hepatitis the patient is.
Other plots for benchmarking and their use
Alternative plots used to benchmark site performances in-
clude caterpillar and funnel plots. Caterpillar plots display
in rank order the point estimate of an outcome with 95%
confidence interval for every site. These have been criti-
cised [19], particularly in the field of education where they
represent league tables for schools based on pupils’ exam
achievements, as the order can be very variable from year
to year and the extreme estimates may still be within the
bounds of an expected distribution. If it is more important
to identify outliers then a funnel plot [20] is often used
[19]. The proportion of the outcome (or the ratio of
observed to expected) is plotted against site size. A
horizontal line is drawn at the population mean (or at 1)
and funnels are drawn to represent 95% (and/or 99%)
confidence limits for the sample means according to site
size. Site estimates of the outcome are then plotted against
site size and those that fall outside the funnel shape are
outliers. Funnel plots can also be drawn centred on
absolute targets rather than the population mean.
However, these plots require complete data on all patients
if they are to be unbiased. They are not suitable for audits
based on random sampling such as our study.
Limitations
The BHIVA audit is a sample of HIV patients attending
each clinic and therefore is not as complete as audits
undertaken in some disease areas where registries exist.
For example, the Renal Registry collects data on all
patients starting dialysis in the UK [21]. The BHIVA
audit committee requested random sampling of patients
attending clinic throughout the year, but included
patients may have been biased towards those attending
clinics at the time of the audit who may be more likely
to be new patients or patients with greater healthcare
needs. Clinics who submitted less than half the patients
requested were omitted from these analyses because we
thought that there might be selection bias. Of note,
clinic size was not associated with sample size. Because
the BHIVA audit is topic-based and does not collect data
on the same outcomes each year, its impact in terms of
improving performance of service delivery is difficult to
judge. However, improvements may be more likely if
locally relevant feedback is given in a clear format which
is easily understood, in addition to receiving reports of
aggregated data. The main concern with implementing
this practice is the cost in terms of time and money.
Nevertheless, the use of the audit data and the design of
a common document template for all sites could minim-
ise these costs.
Future recommendations
It will be important to measure the impact on service
improvement of using performance charts to feedback
clinic-specific benchmarked audit data. This will require
repeat collection of data to assess trends over time.
Incorporating quality control methods for outliers would
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allow clinics to compare their data with previous years
and take rapid action in case of deteriorating outcomes.
As hospitals improve capture of such data, regular audit
will become more feasible.
Conclusion
The BHIVA clinical audit is part of a quality improve-
ment cycle that involves measurement of the delivery of
healthcare for people living with HIV against agreed
evidence-based standards for high quality. In order for
clinicians to take action to bring practice in line with
these standards and so improve the quality of care and
health outcomes, it is necessary to feedback the results
of the audit in a meaningful and impactful format [6].
Based on the BHIVA audit, we have proposed easily di-
gestible visual summaries of locally relevant audit data
that are benchmarked against the overall mean which
can be used for improving HIV services.
We have shown that principal components analysis
can be used to simplify the representation of multiple
correlated audited variables. The aggregated data is more
meaningful when comparing correlated data and allows
both accurate benchmarking against the average per-
formance and against a standard, either of which can be
used to measure future improvements.
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